NOT-CA-18-013: Notice of a Pre-Application Webinar for RFA-CA-17-032, Minority Patient-Derived Xenograft (PDX) Development and Trial Centers (M-PDTCs) (U54)

Notice of a Pre-Application Webinar for RFA-CA-17-032 "Minority Patient-Derived Xenograft (PDX) Development and Trial Centers (M-PDTCs) (U54) "

Notice Number: NOT-CA-18-013

Key Dates
Release Date: October 27, 2017

Related Announcements
RFA-CA-17-032

Issued by
National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a pre-application webinar on Wednesday, November 8, 2017 from 3:00-4:00 PM (EDT) for the Funding Opportunity Announcement (FOA)RFA-CA-17-032, "Minority Patient-Derived Xenograft (PDX) Development and Trial Centers (M-PDTCs) (U54)".

NCI staff members involved in these FOAs will provide orientation and technical assistance to potential applicants by explaining the goals and objectives for the proposed M-PDTCs and answering questions from attendees. Potential applicants are encouraged to submit their questions by November 7th to Tiffany.Wallace@nih.gov .

To join the webinar, registration is required through WebEx. Specific webinar information will be provided upon registration.

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-17-032.

Inquiries

Please direct all inquiries to:

Tiffany Wallace, Ph.D.
National Cancer Institute (NCI)
Telephone:240-276-5114
Email: Tiffany.Wallace@nih.gov